-Medical Internist, Stamford Hospital, 2003-present 

-Deputy Commissioner for Medical and Scientific Affairs, FDA, 2005-2007 

-Resident Fellow, American Enterprise Institute, 2004-2005  

-Senior Adviser to the Administrator, CMS, 2004 

-Director of Medical Policy Development, FDA, 2004   

-Senior Adviser for Medical Technology to the FDA Commissioner, 2003-2004 

-Columnist, Forbes.com, 2007-present

-Author, Forbes-Gottlieb Medical Technology Report, 2004-2005

-Staff Writer, British Medical Journal, 1997-2005

-Author, Gilder Biotech Report, 2000-2002

-Senior Editor, Pulse, Journal of the American Medical Association, 1996-2001

-Health Care Analyst, Alex Brown & Sons (investment bank), 1994-1995

Education
M.D., Mount Sinai School of Medicine
B.A., economics, Wesleyan University

Articles and Short Publications

Measles Madness A Good Framework for Distributing Information on Off-Label Uses From FDA, a Good Framework for Distributing Information on Off-Label Uses

[List All]

Events

Oncology Drug Development: Rethinking FDA Oversight What Should Congress Do about Generic or Follow-On Biologic Drugs? The Perils of Re-importation

[List All]

Speaking Engagements

Access to Information in the People's Republic of China Safety of Chinese Imports Achieving Drug Access and Affordability without Trading on Future Innovation

[List All]